3 Neuroprotective role of EGCG in the context of neurodegenerative diseases Neurodegenerative disease is a common and growing cause of mortality and morbidity worldwide (70), with 152 million people expected to receive the effects of the disease by 2060 (71), including AD, PD, HD, ALS, and prion diseases (72)
Genre: A must-read for anyone taking a GLP-1
van RuitenCCten KulveJSvan BloemendaalLNieuwdorpMVeltmanDJIjzermanRG
Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects
A rat model of hyperthyroidism induced by L-thyroxine injections suggested that L-carnitine might have dose-dependent protective effects against liver damage [59]
Based on this assessment, he may recommend medications such as Semaglutide (Ozempic/Wegovy) or Tirzepatide (Mounjaro)